Compared with the control group, the proliferation level of HNSCC cells decreased with the silencing of CERCAM, and the difference was significant (24 h:ns,48 h:P < 0.05, 72 h:P < 0.01, 96 h:P < 0.001). Here, CERCAM is linked to head and neck squamous cell carcinoma.